Biontech to acquire instadeep to strengthen pioneering position in the field of ai-powered drug discovery, design and development

Mainz, germany, and london, united kingdom, january 10, 2023 – biontech se  (nasdaq: bntx, “biontech”) and  instadeep ltd. (“instadeep”) today announced that they have entered into an agreement under which biontech will acquire instadeep, a leading global technology company in the field of artificial intelligence (“ai”) and machine learning (“ml”). the transaction includes a total upfront consideration of approximately £362 million in cash and biontech shares to acquire 100% of the remaining instadeep shares, excluding the shares already owned by biontech. in addition, instadeep shareholders will be eligible to receive additional performance-based future milestone payments up to approximately £200 million. the transaction follows biontech's initial equity investment as part of instadeep's series b financing round in january 2022.
BNTX Ratings Summary
BNTX Quant Ranking